carmustine has been researched along with Neuroretinitis in 1 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 53-year-old man with multiple myeloma and plasma cell luekemia developed severe, acute bilateral optic neuroretinitis 8 days after chemotherapy with BCNU, procarbazine, cyclophosphamide, and prednisolone." | 7.66 | Optic neuroretinitis in association with BCNU and procarbazine therapy. ( Lennan, RM; Taylor, HR, 1978) |
| "A 53-year-old man with multiple myeloma and plasma cell luekemia developed severe, acute bilateral optic neuroretinitis 8 days after chemotherapy with BCNU, procarbazine, cyclophosphamide, and prednisolone." | 3.66 | Optic neuroretinitis in association with BCNU and procarbazine therapy. ( Lennan, RM; Taylor, HR, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lennan, RM | 1 |
| Taylor, HR | 1 |
1 other study available for carmustine and Neuroretinitis
| Article | Year |
|---|---|
Optic neuroretinitis in association with BCNU and procarbazine therapy.
Topics: Carmustine; Drug Therapy, Combination; Humans; Leukemia, Plasma Cell; Male; Middle Aged; Multiple My | 1978 |